The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Progesterone and Estrogen Regulate Alzheimer-Like Neuropathology in Female 3xTg-AD Mice
Open accessAbstract
Estrogen depletion in postmenopausal women is a significant risk factor for the development of Alzheimer's disease (AD), and estrogen-based hormone therapy may reduce this risk. However, the effects of progesterone both alone and in combination with estrogen on AD neuropathology remain unknown. In this study, we used the triple transgenic mouse model of AD (3xTg-AD) to investigate the individual and combined effects of estrogen and progesterone on β-amyloid (Aβ) accumulation, tau hyperphosphorylation, and hippocampal-dependent behavioral impairments. In gonadally intact female 3xTg-AD mice, AD-like neuropathology was apparent by 3 months of age and progressively increased through age 12 months, a time course that was paralleled by behavioral impairment. Ovariectomy-induced depletion of sex steroid hormones in adult female 3xTg-AD mice significantly increased Aβ accumulation and worsened memory performance. Treatment of ovariectomized 3xTg-AD mice with estrogen, but not progesterone, prevented these effects. When estrogen and progesterone were administered in combination, progesterone blocked the beneficial effect of estrogen on Aβ accumulation but not on behavioral performance. Interestingly, progesterone significantly reduced tau hyperphosphorylation when administered both alone and in combination with estrogen. These results demonstrate that estrogen and progesterone independently and interactively regulate AD-like neuropathology and suggest that an optimized hormone therapy may be useful in reducing the risk of AD in postmenopausal women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 13,416
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Self-citationWest, M. J., Slomianka, L., & Gundersen, H. J. G. (1991) · The Anatomical Record · doi:10.1002/ar.1092310411 · Cited by 2,994
Shumaker, S. A., Legault, C., Rapp, S. R., Thal, L., Wallace, R. B., Ockene, J. K., Hendrix, S. L., Jones III, B. N., Assaf, A. R., Jackson, R. D., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2651 · Cited by 2,178
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
Tang, M.-X., Jacobs, D., Stern, Y., Marder, K., Schofield, P., Gurland, B., Andrews, H., & Mayeux, R. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03356-9 · Cited by 1,647
Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease
Oddo, S. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.08.012 · Cited by 980 · cited 3×
“Colonies of 3xTg-AD (Oddo et al., 2003b) and background strain, wildtype (WT) (C57BL/6/129S; The Jackson Laboratory, Bar Harbor, ME) mice were bred and maintained at the University of Southern California Received June 15, 2007; revised Sept. 27, 2007; accepted Oct. 5, 2007.”
BackgroundMethodResultSelf-citationKawas, C., Resnick, S., Morrison, A., Brookmeyer, R., Corrada, M., Zonderman, A., Bacal, C., Lingle, D. D., & Metter, E. (1997) · Neurology · doi:10.1212/wnl.48.6.1517 · Cited by 966
Rapp, S. R., Espeland, M. A., Shumaker, S. A., Henderson, V. W., Brunner, R. L., Manson, J. E., Gass, M. L. S., Stefanick, M. L., Lane, D. S., Hays, J., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2663 · Cited by 930
Zandi, P. P. (2002) · JAMA · doi:10.1001/jama.288.17.2123 · Cited by 906
Estrogen Deficiency and Risk of Alzheimer's Disease in Women
Paganini-Hill, A., & Henderson, V. W. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117244 · Cited by 853
Espeland, M. A. (2004) · JAMA · doi:10.1001/jama.291.24.2959 · Cited by 795
Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205
Goedert, M., Jakes, R., & Vanmechelen, E. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11484-e · Cited by 608
Estrogen Replacement Therapy and Risk of Alzheimer Disease
Paganini‐Hill, A. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.156.19.2213 · Cited by 524
Hogervorst, E., Williams, J., Budge, M., Riedel, W., & Jolles, J. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00410-3 · Cited by 439
Brain estrogen deficiency accelerates Aβ plaque formation in an Alzheimer's disease animal model
Yue, X., Lu, M., Lancaster, T., Cao, P., Honda, S.-I., Staufenbiel, M., Harada, N., Zhong, Z., Shen, Y., & Li, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505203102 · Cited by 388
Pike, C. J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.721552.x · Cited by 387
Self-citationTemporal Profile of Amyloid-β (Aβ) Oligomerization in an in Vivo Model of Alzheimer Disease
Oddo, S., Caccamo, A., Tran, L., Lambert, M. P., Glabe, C. G., Klein, W. L., & LaFerla, F. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m507892200 · Cited by 379 · cited 2×
“In preliminary slot blot studies using an oligomeric-specific anti-A antibody, we observed elevated levels of oligomeric A in aged female 3xTg-AD mice (our unpublished observations), consistent with a previous report (Oddo et al., 2006a).”
ResultSelf-citationNeuroprotective Effects of Female Gonadal Steroids in Reproductively Senescent Female Rats
Alkayed, N. J., Murphy, S. J., Traystman, R. J., & Hurn, P. D. (2000) · Stroke · doi:10.1161/01.str.31.1.161 · Cited by 333
Roof, R. L., Duvdevani, R., Braswell, L., & Stein, D. G. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1147 · Cited by 321
Oddo, S., Vasilevko, V., Caccamo, A., Kitazawa, M., Cribbs, D. H., & LaFerla, F. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608485200 · Cited by 283
Self-citationBehavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months
King, D. L., & Arendash, G. W. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00639-x · Cited by 242
Ovariectomy and 17β-estradiol modulate the levels of Alzheimer’s amyloid β peptides in brain
Petanceska, S. S., Nagy, V., Frail, D., & Gandy, S. (2000) · Neurology · doi:10.1212/wnl.54.12.2212 · Cited by 224
Klyubin, I., Walsh, D. M., Shankar, G. M., Townsend, M., Fadeeva, J. V., Betts, V., Podlisny, M. B., Cleary, J. P., Ashe, K. H., Rowan, M. J., et al. (2005) · Biochemical Society Transactions · doi:10.1042/bst20051087 · Cited by 206
The Women's Health Initiative Memory Study: findings and implications for treatment
Craig, M., Maki, P. M., & Murphy, D. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)01016-1 · Cited by 197
Modulation of Aβ peptides by estrogen in mouse models
Zheng, H., Xu, H., Uljon, S. N., Gross, R., Hardy, K., Gaynor, J., Lafrancois, J., Simpkins, J., Refolo, L. M., Petanceska, S., et al. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00690.x · Cited by 175
Effects of gonadal hormone replacement on measures of basal forebrain cholinergic function
Gibbs, R. B. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00433-4 · Cited by 170
Bimonte‐Nelson, H. A., Francis, K. R., Umphlet, C. D., & Granholm, A. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04867.x · Cited by 170
Learning Decreases Aβ*56 and Tau Pathology and Ameliorates Behavioral Decline in 3xTg-AD Mice
Billings, L. M., Green, K. N., McGaugh, J. L., & LaFerla, F. M. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4800-06.2007 · Cited by 161
Self-citationRosario, E. R., Carroll, J. C., Oddo, S., LaFerla, F. M., & Pike, C. J. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2514-06.2006 · Cited by 160
Self-citationEstradiol Prevents Neural Tau Hyperphosphorylation Characteristic of Alzheimer's Disease
Rodríguez, M. Á. D. L. R., Silva, I., Nilsen, J., Pérez, M., García‐Segura, L. M., Ávila, J., & Naftolin, F. N. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1347.016 · Cited by 160
Hoffman, G. E., Moore, N. D., Fiskum, G. M., & Murphy, A. Z. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00104-3 · Cited by 135
Glycogen synthase kinase 3β links neuroprotection by 17β-estradiol to key Alzheimer processes
Goodenough, S., Schleusner, D., Pietrzik, C. U., Skutella, T., & Behl, C. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.12.029 · Cited by 135
Levin-Allerhand, J. A., Lominska, C. E., Wang, J. R., & Smith, J. D. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4601 · Cited by 129
Impact of Estrogen Therapy on Alzheimer??s Disease
Brinton, R. D. (2004) · CNS Drugs · doi:10.2165/00023210-200418070-00001 · Cited by 109
Ovariectomy and 17β-estradiol modulate the levels of Alzheimer's amyloid β peptides in brain
Petanceska, S. S., Nagy, V., Frail, D. E., & Gandy, S. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00157-1 · Cited by 109
Progesterone counteracts estrogen-induced increases in neurotrophins in the aged female rat brain
Bimonte‐Nelson, H. A., Nelson, M. E., & Granholm, A. (2004) · Neuroreport · doi:10.1097/00001756-200412030-00021 · Cited by 109
Ishizawa, T., Sahara, N., Ishiguro, K., Kersh, J. S., McGowan, E. M., Lewis, J. M., Hutton, M. L., Dickson, D. W., & Yen, S.-H. C. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63465-7 · Cited by 99
Toung, T. J. K., Chen, T., Littleton‐Kearney, M. T., Hurn, P. D., & Murphy, S. J. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000135594.13576.d2 · Cited by 98
Progesterone treatment of spinal cord injury: effects on receptors, neurotrophins, and myelination
De Nicola, A. F., Gonzalez, S. L., Labombarda, F., Deniselle, M. C. G., Garay, L., Guennoun, R., & Schumacher, M. (2006) · Journal of Molecular Neuroscience · doi:10.1385/jmn:28:1:3 · Cited by 92 · cited 1×
“…suggests that progesterone improves hippocampal-dependent spatial memory (Roof et al., 1994) and protects neurons in some (Roof et al., 1994; Alkayed et al., 2000; Hoffman et al., 2003; De Nicola et al., 2006) but not all (Azcoitia et al., 1999; Toung et al., 2004) rodent models of neuronal injury.”
BackgroundMaki, P. M. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1347.012 · Cited by 85
Gonadal hormones affect neuronal vulnerability to excitotoxin-induced degeneration
Azcoitia, Í., Fernández‐Galaz, C., Sierra, A., & García‐Segura, L. M. (1999) · Journal of Neurocytology · doi:10.1023/a:1007025219044 · Cited by 84
Heikkinen, T., Kalesnykas, G., Rissanen, A., Tapiola, T., Iivonen, S., Wang, J., Chaudhuri, J., Tanila, H., Miettinen, R., & Puoliväli, J. T. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.01.015 · Cited by 83
Progestins inhibit the neuroprotective effects of estrogen in rat hippocampus
Rosario, E. R., Ramsden, M., & Pike, C. J. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.127 · Cited by 64
Self-citationKadish, I., & van Groen, T. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-10-04095.2002 · Cited by 57
Estrogen Therapy Fails to Alter Amyloid Deposition in the PDAPP Model of Alzheimer’s Disease
Green, P. S., Bales, K. R., Paul, S. M., & Bu, G. (2005) · Endocrinology · doi:10.1210/en.2004-1433 · Cited by 54
Cummings, B. J., Mason, A. J. L., Kim, R. C., Sheu, P. C. ‐., & Anderson, A. J. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00316-5 · Cited by 44
Guerra‐Araiza, C., Amorim, M. A. R., Camacho‐Arroyo, I., & García‐Segura, L. M. (2007) · Developmental Neurobiology · doi:10.1002/dneu.20383 · Cited by 42
Schneider, L. S. S. (2004) · JAMA · doi:10.1001/jama.291.24.3005 · Cited by 31
Comparison of estrogen and androgen levels after oral estrogen replacement therapy.
Slater, C. C., Zhang, C., Hodis, H. N., Mack, W. J., Boostanfar, R., Shoupe, D., Paulson, R. J., & Stanczyk, F. Z. (2001) · PubMed · Cited by 26
Self-citationShultz, J. M., Zhu, X. D., Knopp, R. H., LeBoeuf, R. C., & Rosenfeld, M. E. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.05.069 · Cited by 6
Cited by
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Self-citationYao, J., Irwin, R. W., Zhao, L., Nilsen, J., Hamilton, R. T., & Brinton, R. D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903563106 · Cited by 940
“This transgenic mouse strain bears mutations in three genes (human APPSWE, TauP301L, and PS1M146V genes) linked to AD and frontotemporal dementia (FTD) and exhibits an age-related neuropathological phenotype, including both amyloid beta (A ) deposition and tau hyperphosphorylation (16, 18).”
BackgroundWebster, S. J., Bachstetter, A. D., Nelson, P. T., Schmitt, F. A., & Van Eldik, L. J. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00088 · Cited by 755
“…2013), 27: (Devi and Ohno, 2010), 28:(Devi and Ohno, 2012), 29: (Urano and Tohda, 2010), 30: (Oddo et al., 2003), 31: (Clinton et al., 2007), 32: (Carroll et al., 2007), 33: (Gimenez-Llort et al., 2007), 34: (Billings et al., 2005), 35: (Nelson et al., 2007b), 36: (Pietropaolo et al., 2008),…”
Progesterone receptors: form and function in brain
Brinton, R. D., Thompson, R. F., Foy, M. R., Baudry, M., Wang, J., Finch, C. E., Morgan, T. E., Pike, C. J., Mack, W. J., Stanczyk, F. Z., et al. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.02.001 · Cited by 675
Self-citationProtective actions of sex steroid hormones in Alzheimer’s disease
Pike, C. J., Carroll, J. C., Rosario, E. R., & Barron, A. M. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.04.015 · Cited by 522
Self-citation
Metadata
- Authors
- Carroll, J. C., Rosario, E. R., Chang, L., Stanczyk, F. Z., Oddo, S., LaFerla, F. M., & Pike, C. J.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2007-11-28
- Volume
- 27
- Issue
- 48
- Pages
- 13357-13365
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W1983282794
- Cited by
- 364
- References
- 51
- FWCI
- 11.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.